Dear Fabien,

Cases like that crop up from time to time. You shouldn't treat this peptide
in any way differently than any other peptide. If you're reasonably sure
about the peptide's sequence - BLAST it against a wide database (nr for
example). Like others pointed out, just make sure that it's not a piece of
something that's already part of your principal polypeptide. The latter is
very common (but could be easily verified).

Sequence-wise I am sure I don't have to mention that at 2.2A there is a lot
of possible ambiguity: D/N, Q/E, K/R/Q (disordered end), T/V, and so forth.

Artem


-----Original Message-----
From: CCP4 bulletin board [mailto:[email protected]] On Behalf Of Fabien
Bergeret
Sent: Friday, October 30, 2009 10:09 AM
To: [email protected]
Subject: [ccp4bb] Supplementary density

Hello

We’re resolving a structure of a soluble protein and in the electronic 
density map (maximum resolution at 2.2Å), we observe a supplementary 
density that does not belong to the protein. This density is present in 
two different crystalline forms obtained in different crystallization 
conditions.
This density could be represented by an oligopeptide ~10 residues long 
for which there is no ambiguity about its polarity. Furthermore, side 
chains are quite easily visible and a sequence can therefore be assigned.
The deduced sequence doesn’t belong to the sequence of the protein of 
interest, meaning that the oligopeptide has been co-purified and 
co-crystallized.

Has somebody met a similar situation? Could you please give us some 
advices in terms of refinement, validation, etc.?

Thanks in advance

Best regards


Fabien
PhD student
[email protected] <mailto:[email protected]>

Reply via email to